Jones Trading Initiates Coverage On Editas Medicine With Buy Rating, Announces Price Target of $13
Jones Trading Initiates Coverage On Editas Medicine With Buy Rating, Announces Price Target of $13
Jones Trading開始對Editas Medicine進行買入評級，並宣佈目標股價爲13美元。
Jones Trading analyst Soumit Roy initiates coverage on Editas Medicine (NASDAQ:EDIT) with a Buy rating and announces Price Target of $13.
Jones Trading的分析師Soumit Roy以買入評級啓動了對Editas Medicine（納斯達克：EDIT）的覆蓋，並宣佈了13美元的目標價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。